cbp-201
Showing 1 - 6 of 6
Atopic Dermatitis Trial in United States (CBP-201, Placebo)
Withdrawn
- Atopic Dermatitis
- CBP-201
- Placebo
-
Little Rock, Arkansas
- +8 more
Jan 4, 2023
Atopic Dermatitis Trial in China (CBP-201)
Not yet recruiting
- Atopic Dermatitis
- CBP-201
-
Beijing, Beijing, China
- +40 more
Jun 14, 2023
Chronic Rhinosinusitis With Nasal Polyps Trial in Worldwide (CBP-201, Placebo)
Terminated
- Chronic Rhinosinusitis With Nasal Polyps
- CBP-201
- Placebo
-
Birmingham, Alabama
- +67 more
Jun 29, 2022
Moderate to Severe Persistent Asthma Trial in United States (CBP-201, Placebo)
Recruiting
- Moderate to Severe Persistent Asthma
- CBP-201
- Placebo
-
Huntington Beach, California
- +21 more
May 16, 2021
Moderate-to-severe Atopic Dermatitis Trial in Worldwide (CBP-201, )
Completed
- Moderate-to-severe Atopic Dermatitis
- CBP-201
- placebo
-
Glendale, Arizona
- +58 more
Feb 24, 2022
Moderate-to-severe Atopic Dermatitis Trial in China (CBP-201, Placebo)
Recruiting
- Moderate-to-severe Atopic Dermatitis
- CBP-201
- Placebo
-
Hefei, Anhui, China
- +55 more
Sep 22, 2021